Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing
Vaccine Therapy in Treating Patients With Multiple Myeloma
Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)